New Egyptian Journal of Medicine [The]. 2007; 37 (6 Supp.): 73-79
in English
| IMEMR
| ID: emr-187291
ABSTRACT
Hepatic ischemia/reperfusion [I/R] injury is the main cause of hepatic damage and is inevitable after hepatic surgery, liver transplantation, shock, trauma. Despite the recent improvements in liver preservation and surgical techniques, hepatic I/R injury remains an important clinical complication. To control this complicated physiological as well as pathological process, further studies are required to find out the key pathway and a novel therapeutic approach. PPAR gamma may be a protective regulator against ischemic damage. The aim of this study is to study the effect of pioglitazone on hepatic ischemic-reperfusion injury and compare its effect with ischemic preconditioning
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Rats
/
Protective Agents
/
Thiazolidinediones
/
Antioxidants
Limits:
Animals
Language:
English
Journal:
New Egypt. J. Med.
Year:
2007
Similar
MEDLINE
...
LILACS
LIS